Arterial RESULTS Overall, the interval from symptom onset to diagnosis was similar post-protocol compared to pre-protocol (20.3 vs 22.7h; p=0.109), although mild strokes (Pediatric National Institute of Health Stroke Scale [PedNIHSS] 0-4), were diagnosed faster post-protocol (12.1 vs 36.3h; p=0.003). Magnetic resonance imaging (MRI) was the initial diagnostic modality more often post-protocol (25% vs 1.4%; p<0.001). Initial MRI was more accurate for diagnosing stroke than initial CT (100% vs 47%; p<0.001) with similar time-to-diagnosis. The proportion of children receiving antithrombotic medication within 24 hours doubled in the post-protocol period (83% vs 36%; p<0.001).
Delays in diagnosing and treating children with acute stroke are a persisting challenge. In children with arterial ischemic stroke (AIS), rapid treatment with neuroprotection, antithrombotic medications, and potentially tissue plasminogen activator (tPA) are recommended to limit infarct severity and stroke recurrence. [1] [2] [3] [4] However, delays in diagnosis preclude timely treatment, potentially increasing the likelihood of poor outcome. Children present age-related challenges to timely diagnosis, including stroke mimics in 30% to 75% and subtle clinical presentations, which necessitates neuroimaging confirmation of stroke before administering treatment. [5] [6] [7] Seizures in 22% to 25% at pediatric stroke onset (10-fold increase over adults) confound stroke diagnosis, accelerate ischemic injury, and entail urgent consideration of anticonvulsants for neuroprotection. 8, 9 Studies to date, however, report intervals of 16 to 25 hours from symptom onset to stroke diagnosis 1, 8, [10] [11] [12] [13] [14] far beyond 4.5 to 6 hours, the time window recommended for thrombolysis or embolectomy in adults. 2, 15 In adult stroke centers, comprehensive stroke protocols increase access to stroke treatment, decreasing costs, and improving outcomes. 2, [16] [17] [18] [19] Referral of children with acute stroke to centers with pediatric stroke teams is now recommended. 8 Such centers employ acute stroke protocols (ASPs), a relatively new phenomenon. 7, 20 Such protocols are labor-and cost-intensive and whether they improve diagnosis or treatment in children remains minimally studied. We initiated a specialized Children's Stroke Service at The Hospital for Sick Children (SickKids) in 1998. In 2005, we reported median delays to diagnosis of 22.7 hours, and to treatment of 1 to 2 days in children with acute stroke. 8 Children with milder strokes (low Pediatric National Institute of Health Stroke Scale
[PedNIHSS] scores) had the greatest delays to diagnosis. We consequently initiated a hospital-wide ASP in 2005 to accelerate clinical stroke recognition, neuroimaging access (especially magnetic resonance imaging [MRI] ), and antithrombotic (aspirin, anticoagulants), neuroprotective, and, when appropriate, tPA treatment.
Building from our previous work, 8 we aimed in the current study to compare delays in diagnosis and treatment in children with AIS diagnosed before and after implementing our ASP.
METHOD Participants
We prospectively enrolled children diagnosed with AIS at SickKids, from January 1992 to December 2012. SickKids is a large tertiary pediatric hospital with 370 ward and intensive care beds, and an Emergency Department that sees approximately 64 000 patients annually. 21 The catchment area includes the city of Toronto with a pediatric population of more than 1.2 million. 22 Children were enrolled into the institutional Canadian Pediatric Ischemic Stroke Registry in two sequential cohorts: the pre-protocol and post-protocol cohorts. The 'pre-protocol' cohort consists of the 209 children with AIS diagnosed from January 1992 to December 2004 and included in our previous analysis. 8 We compared data from those children to a more recent 'post-protocol' cohort of children with AIS diagnosed from January 2005 to December 2012. SickKids's research ethics board approval and parental consent were obtained.
Inclusion criteria
The inclusion criteria were as follows: first, age 1 month to 18 years at diagnosis of index AIS; second, AIS event within 14 days preceding diagnosis; third, abrupt onset of a focal or non-focal neurological deficit(s) or seizures; fourth, computed tomography (CT) and/or MRI showing focal infarction conforming to an established arterial territory consistent with the clinical presentation.
Exclusion criteria
The exclusion criteria were as follows: first, isolated transient ischemic attacks; second, clinically silent AIS; third, missed diagnosis defined as AIS diagnosed 14 or more days after clinical onset; fourth, medical chart unavailable for review.
Data collection
The Registry database was supplemented by focused rereview of health records to extract additional data on timing of clinical onset, hospital arrival, neuroimaging studies, diagnosis, and antithrombotic treatment. 8 Definitions and computations for time intervals in the post-protocol cohort were identical to those published. 8 
Clinical data
Age at stroke, sex, stroke risk factors (cardiac, vasculopathy, acute or chronic systemic disorders), clinical presentation (focal neurological deficit, diffuse neurological deficits, seizures), antithrombotic or tPA treatment and outcome (death, last Pediatric Stroke Outcome Measure [PSOM] score) were collected. 23 Neuroimaging data included test type (CT, MRI), timing (date, hour), location (hospital where performed), and result (normal, confirmed AIS or other abnormal).
For children aged 4 months to 18 years, initial stroke severity was measured using the PedNIHSS at bedside testing or retrospective chart scoring. 24 PedNIHSS scoring for infants aged 4 months to 2 years utilized scoring instructions adapted for this age group from the original PedNIHSS measure (although not included in the validation study). 24 Scores range from 0 (no deficit) to 42 (maximal deficit). We analyzed children with PedNIHSS scores below 5 separately. 8, 24 Acute stroke protocol
The protocol, instituted in 2005, included a 4-point stroke-screening tool (focal neurological deficit, sudden onset; age ≥6y; and symptoms present <5h from last seen well) (Fig. S1 , online supporting information). For children meeting all four criteria, the physician from emergency room, hospital ward, or outside SickKids paged the stroke fellow on call immediately. Based on the history, the Stroke Team decided whether to activate Code Stroke, which instituted paged to neurology, neuroradiology (diagnostic and interventional), anesthesia, thrombosis, and critical care teams. MRI first-imaging test policy was instituted and neuroprotective goals provided (Fig. S1 ). For possible tPA candidates, preparation for tPA administration was initiated. To advertise the protocol, Stroke Code Alert posters and 1-hour professional educational sessions were implemented across subspecialty departments (neurology, anesthesia, emergency, neuroradiology, critical care). Stroke recognition was added to Emergency Department Nurse role expectations.
Before 2005 there was no Code Stroke system in place. All services were separately paged at the discretion of the responsible physician. Urgent MRI and neuroprotective or tPA guidelines were not available. However, antithrombotic treatment guidelines were available from 1995 continuously in the hospital's formulary. Consultation with a pediatric stroke neurologist was available to other neurology staff 24/7 from 1998.
Study outcomes
The study outcomes were as follows: changes over the two study periods (pre-and post-protocol) in time-to-diagnosis, mode of initial imaging, and time to antithrombotic treatment. The in-hospital component of delay to diagnosis or What this paper adds
• After pediatric acute stroke protocol (ASP), 'MRI 1st and only test' can replace initial computed tomography without delaying diagnosis.
• After ASP, children receive antithrombotic treatment faster and more often.
• After ASP, mild strokes are diagnosed more quickly.
treatment was the main outcome applicable for both outpatient (after hospital arrival) and in-patient strokes. Times of symptom onset, hospital arrival, physician's assessment, first neuroimaging test, diagnostic neuroimaging test, and antithrombotic stroke treatment were documented. Stroke onset was defined as the time recorded by ambulance personnel or Emergency Room records for the onset of symptoms or signs of stroke, or based on parent report, and the onset time documented by the nurse or physician's notes. When exact time of onset was not recorded, time was estimated from all available recorded data. 8 Time of diagnosis was defined as the time of completion of the neuroimaging study that confirmed AIS.
Time of treatment was defined as time that antithrombotic medication (aspirin, clopidogrel, or heparin) was provided to the patient and signed off in the patient record by the nurse. Because of limited health record data before 2005, time-to-treatment for pre-protocol cohort was classified as within 24 hours, between 24 to 48 hours, or beyond 48 hours. For comparison, times of treatment in the postprotocol cohort were coded by 24-hour epochs as for the pre-protocol cohort. Because some patients were already receiving antithrombotic therapies, only those with treatment changes post-stroke were counted as antithrombotic therapy for AIS.
Statistical analysis
Medians and interquartile ranges for all measures of delays were calculated. Pre-protocol and post-protocol cohorts were compared using the Wilcoxon rank-sum test for continuous variables and Fisher's exact test for categorical variables. 25 Putative predictors of the primary outcome, in-hospital delays to diagnosis, were selected based on previously published literature. 8 Independent variables include age, Ped-NIHSS, out-patient status, focal or non-focal deficits, initial imaging modality (MRI, CT), required repeat imaging, seizures, mode of stroke onset, altered consciousness, risk factors, coronary heart disease, number and laterality of infarcts, and circulation territory of stroke. We employed one-way analysis of variance (ANOVA) for categorical and linear regression for continuous variables. Because of skewed distribution, the outcome variable for these analyses was log-transformed to achieve normality. Levene's tests were conducted to verify homogeneity of variance for ANOVA. Variables that were significant at 10% level (p<0.1) in univariate analyses were entered into multivariable analysis using non-parametric bootstrapping (reps=1000). 26 Analyses were conducted with RStudio (2015, Boston, MA, USA).
RESULTS
We included 112 children (60 males, 52 females; median age 5. (Table I ). Twenty-four additional patients were screened for the post-protocol cohort but excluded because of missing consent (4), old or incidental infarct (6), AIS diagnosis more than 14 days from onset (2), transient ischemic attacks or strokes preceding the AIS event (7), and missing documentation on timing (5) (Fig. S2 , online supporting information). Table I outlines patient demographic and clinical characteristics. Median age was 4 years 9 months in the pre-protocol cohort and 5 years 9 months in the post-protocol cohort (Table I) .
Clinical characteristics
Stroke onset with focal neurological deficits occurred at similar rates in both cohorts (Table I) . Risk factors for AIS were similar across cohorts and included cardiac (36% pre and 41% post); vasculopathy (44% pre and 39% post), and other conditions. Among in-patients, 24 (58%) children were in a critical care unit at AIS onset, of whom approximately half had cardiac disease. Stroke severity was similar across cohorts with PedNIHSS median score 7 in both, and scores below 5 in 36% post-protocol and 29% preprotocol. Antithrombotic treatment was received by 72% of post-protocol compared to 63% pre-protocol (Table I) . One child in each cohort received tPA. PSOM scores were unavailable for the 35 children who died (25 pre-protocol; 10 post-protocol), 21 children admitted before 1996 (when the PSOM became available), and 21 were lost to followup. The median PSOM score was 1.0 (mild deficit) in both cohorts.
Imaging diagnosis
The use of MRI as the initial imaging modality increased significantly post-protocol (25% vs 1.4% pre-protocol; p<0.001; Table II ). MRI was 100% successful in diagnosing AIS. CT as initial imaging was unsuccessful at diagnosing AIS in 47% pre-protocol and in 53% postprotocol, necessitating repeat imaging to diagnose AIS (MRI for 88% of children post-protocol; data not shown).
Analysis of delays
Total delay from symptom onset to diagnosis was median 20.3 hours post-protocol and 22.7 hours pre-protocol (p=0.109; Table II ). The time of symptom onset was exact in 53 (47%) and estimated in 59 (53%) post-protocol children. A similar proportion of children were diagnosed within 4.5 hours (11.7% post-protocol vs 14.8% pre-protocol), and within 6 hours (18% post protocol vs 20.1% pre-protocol). In-hospital delay, the primary study outcome, was similar pre-and post-protocol (median 11.3h
post-protocol and 13.8h pre-protocol; p=0.420). However, in children with milder PedNIHSS scores (<5) it was substantially reduced from median 36.3 pre-protocol to 12.1 hours post-protocol (p=0.003).
In children with out-patient stroke, the total delay to diagnosis was reduced by 6.7 hours (median 22.4 post-protocol vs 29.1 pre-protocol; p=0.051). The pre-hospital component of delay was median 2.2 hours post-protocol, similar to pre-protocol (1.7h).
Time to initial imaging was 4.2 hours shorter post-protocol in children with in-patient strokes (median 10.5 vs 6.3h, p=0.049) and was 1.5 hours longer in children with out-patient strokes (median 4.7h post-protocol vs 3.2h; p=0.037) consistent with the increased use of initial MRI. Despite out-patients waiting longer for initial imaging post-protocol, the time-to-diagnosis of stroke tended to be shorter (p=0.051) and the need for repeat imaging studies to confirm stroke reduced (p=0.039).
The proportion of children receiving antithrombotic treatment was, overall, similar across cohorts (72% postprotocol vs 63% pre-protocol; Table III ). However, for inpatient strokes treatment rates significantly increased (58% vs 38%, p=0.024). Initiation of antithrombotic treatment within 24 hours of diagnosis more than doubled post-protocol from 36.1% pre-protocol to 83.6% (p<0.001). Median time to treatment post-protocol was 8.0 hours post-diagnosis and 44% received treatment within 6 hours of diagnosis (Fig. S3, online supporting information) . The reduced time from diagnosis to treatment is seen for both out-patient (median 1d pre-protocol vs 7.5h post-protocol) and in-patient (median 2d pre-protocol vs 13h post- The majority of in-hospital arterial ischemic stroke occurred in critical care settings while under close observation. The time interval from symptom onset to physician assessment for in-patients was 0. In-hospital delays calculated from hospital arrival for out-patient strokes, and symptom onset for in-patient strokes. Median hours (interquartile range) unless otherwise specified n (%). Eighty percent in-hospital delays available pre-protocol; 96% available post-protocol; 100% availability of initial imaging type and ensuing status of arterial ischemic stroke diagnosis. MRI, magnetic resonance imaging; PedNIHSS, Pediatric National Institute of Health Stroke Scale.
protocol), although difference between groups cannot be statistically shown because of the difference in units utilized in data collection (days for pre-protocol and hours for post-protocol). The antithrombotic treatment type shifted towards anticoagulation post-protocol (60% vs 46% pre-protocol, p=0.012; Table III) .
We could not measure an association between timely treatment and clinical outcome across protocols because the PSOM follow-up intervals were at different stages of recovery (median 4y [range 0-16y] pre-protocol vs 1.5y [range 0-8y] post-protocol; p<0.001).
Predictors of in-hospital delay
In the post-protocol cohort, associations with longer inhospital delay were, on univariate analysis (Table IV) , as follows: presentation without focal neurological deficits (F 1,75 =3.2, p=0.076); failure to diagnose AIS after initial imaging (F 1,105 =43.1, p<0.001); and posterior circulation stroke (F 2,100 =4.25, p=0.017). In multivariate analysis, only failure to diagnose AIS after initial imaging remained significant (F 1,68 =42.7, 95% confidence interval: 19.1-86.2, p=0.009).
DISCUSSION
We studied the impact of an ASP at our pediatric institution on time-to-diagnosis and time-to-treatment in children with stroke. Our main findings are that the protocol was associated with a two-fold increase in the proportion of children receiving antithrombotic treatment within 24 hours of onset, faster diagnosis for children with mild neurological deficits, a trend to faster diagnosis in outpatient strokes, and more rapid access to initial imaging for in-patient strokes. Our overall median time-to-diagnosis remained at or beyond 20 hours both pre-and postprotocol. Compared with adults, the diagnosis of acute stroke is reported to be very prolonged in children. 1, 8, [10] [11] [12] [13] [14] Nevertheless, in our study nearly one-fifth of children were diagnosed within 6 hours and 12% within 4.5 hours of onset, supporting the feasibility of early stroke interventions including neuroprotective, recanalization, and antithrombotic treatments recommended in pediatric stroke treatment guidelines. [2] [3] [4] In our study, the only independent predictor of delay to diagnosis was a failure to diagnosis AIS after initial imaging. This is consistent with previous studies' conclusions that delayed diagnosis because of initial CT is an important contributor to diagnostic delays. 8, 14 The ASP was designed to increase timely diagnosis and initiation of stroke treatments, encouraging high clinical suspicion and emergency MRI for diagnosing stroke. We anticipated that MRI would require additional time compared to initial CT, and that MRI would also avoid ionizing radiation, reduce the need for dual imaging, and potentially shorten the overall time to diagnosis. Indeed post-protocol we did observe an increased time to initial imaging, however time to diagnosis was not increased and repeat imaging tended to be less frequent (p=0.039). Initial CT was false negative in 53% of children consistent with Includes one child from each cohort who received tissue plasminogen activator.
c Patient received both antithrombotic and antiplatelet treatment. OR (95% CI), odds ratios calculated between post-and pre-protocol cohorts (95% confidence interval); NA, not applicable. published rates and necessitating dual imaging. 10, [12] [13] [14] MRI is not always feasible in children with acute stroke, including children with cardiac disorders and ventricular assist device, pacemakers, or other in-dwelling devices, and those who would require sedation but in whom sedation is not feasible. A recent study provides strong evidence that rapid MRI for diagnosing childhood stroke is achievable. The study, conducted from 2011 to 2014 reported 124 stroke alerts in a pediatric emergency room, including 30 children with stroke. 7 MRI, the initial imaging study in 76%, was completed at median 94 minutes from hospital arrival compared to 59 minutes for CT. These data prove the feasibility of rapid MRI as a first imaging test and provide a criterion standard to which all specialized pediatric stroke centers can aspire.
Our most significant finding was that the proportion of children receiving antithrombotic treatment within 24 hours more than doubled after implementing the protocol. Recurrent stroke occurs in 10% to 25% of children, and recurrences are frequently in the first week poststroke, supporting the need for early initiation of antithrombotic treatment. [2] [3] [4] Ascertaining the onset of neuroprotective treatment strategies (reduction of fever, seizures and normalization of blood glucose, blood pressure, and oxygenation), while important, was not feasible to collect. Overall, deaths and PSOM scores did not demonstrate improvement post-protocol despite earlier treatments, a finding possibly attributable to a longer interval of poststroke recovery at final PSOM examination in the pre-protocol children. However, we did not assess recurrent stroke outcomes, a more relevant target for antithrombotic treatment. This is a potential subject for future research.
Children with out-patient stroke demonstrated a trend to reduced time-to-diagnosis post-protocol of 6.7 hours. Their rate of initial imaging with MRI increased post-protocol to 28%. Because diagnosis was immediate in these patients, dual imaging was avoided. Therefore with an MRI-first policy, the avoidance of ionizing radiation was achieved without increasing the time-to-diagnosis. Community-wide education campaigns training children, parents, teachers, and pediatricians (General and Emergency Room) to recognize the signs and symptoms of pediatric stroke could, however, reduce such delays. No such initiatives currently exist.
For out-patient strokes, pre-hospital delays of median 1.7 hours pre-and 2.2 hours post-protocol likely reflect the ongoing gaps in public awareness of pediatric stroke. Delayed recognition of stroke by parents and teachers, and frequent non-ambulance transportation to hospital were specifically noted in our study. 8 However, the overall shortening of time-to-diagnosis for out-patient strokes supports a beneficial impact of the ASP in the emergency department setting, where we provided a stroke screening tool and protocol education sessions. Overall, in-patient strokes had longer in-hospital time-to-diagnosis compared to out-patient strokes reflecting the complex clinical status of children who suffer strokes while in hospital for other illnesses. Often these children were in intensive care units and sedated, making clinical detection difficult. They were also frequently too medically unstable for diagnostic imaging. Despite this, time to initial imaging was significantly shortened to median 6.3 hours post-protocol and MRI was feasible as initial imaging in 19.5% of in-patients. Although there was no improvement in the interval from hospital arrival to initial physician assessment, it would be beneficial to analyze time from hospital arrival to time that a stroke was suspected. This is difficult to obtain retrospectively as the urgent nature of these consults often leads to less comprehensive documentation.
Limitations to our study relate to the retrospective nature of data collection. Symptom onset needed to be estimated in half our participants when exact time of symptom onset was not available. The pre-protocol dataset had limited data on exact time of treatment initiation. The prolonged study period over 14 years could have encompassed practice changes independent of our protocol, including increased use of MRI. However, prospective enrolment of patients, and the comparison of diagnostic delays and treatment in response to an ASP are unique strengths of our study.
Although current published pediatric stroke guidelines do not include ASPs, they do emphasize the need for involvement of pediatric neurologists with stroke expertise to facilitate urgent diagnosis, neuroprotective care, and potentially thrombolysis in adolescents. [1] [2] [3] [4] 20 The publication in 2014 of the first criteria for establishment of pediatric acute stroke centers included elements consistent with our 2005 ASP (24/7 pediatric stroke team, emergency department/intensive care unit order sets, 24/7 MRI availability). 20 Together with our study findings, future consensus-based guidelines for pediatric stroke care may well recommend ASPs to increase timely access to stroke treatment (e.g. Level C, American Heart Association guidelines).
In summary, the implementation of an ASP in our children's hospital reduced the time to administration of secondary preventive antithrombotic treatment and reduced the need for dual imaging and ionizing radiation. In addition, there were no diagnostic delays associated with increased use of MRI. However, prompt diagnosis of pediatric AIS remains challenging. As seen in adult stroke, faster treatment in children should translate into faster recoveries, fewer recurrent strokes, decreased healthcare costs and likely, improved patient outcome. 4 As new urgent stroke treatments increase, earlier stroke recognition and treatment will be paramount. The current study supports that ASPs are a step towards achieving this goal for children with stroke.
SUPPORTING INFORMATION
The following additional material may be found online:
Appendix S1: Additional authors. Figure S1 : Acute Stroke Protocol (2005 version, now historical) developed by the Children's Stroke Program at SickKids hospital for screening, diagnosing, and treating children with suspected stroke. Figure S2 : Screening and assessment of eligibility for pre-and post-protocol cohort. Figure S3 : Post-protocol initiation of treatment intervals.
